Bill > HR2172

This bill aims to improve Medicare coverage for home infusion therapy by making several key modifications to existing law. The bill expands the definition of home infusion services to include pharmacy services, drug preparation, and coordination of care, and allows nurse practitioners and physician assistants to establish and review home infusion care plans. It introduces a new payment structure for home infusion therapy, ensuring that Medicare will pay for each day a drug is administered, even if the qualified home infusion therapy supplier is not physically present in the patient's home. The bill also clarifies billing for non-pump drugs and biologicals, specifically antibacterial, antifungal, and antiviral medications administered intravenously. Additionally, the legislation modifies payment rules for home infusion supplies, preventing duplicate billing for specific supplies like tubing, catheters, and dressings when they are furnished on the same day as home infusion therapy. These changes are set to take effect on January 1, 2026, and are designed to preserve and expand patient access to home-based medical treatments under the Medicare program.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/2172/all-info